Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04634227 · ClinicalTrials.gov registry record · Early Phase 1
Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)
A Early Phase 1 study of Sarcoma and Soft Tissue Sarcoma, sponsored by University of Iowa.
- Active
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT04634227 is a Early Phase 1 study of Sarcoma and Soft Tissue Sarcoma that is active but no longer recruiting, run by University of Iowa. The registered enrollment target is 30 participants, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04634227, a Early Phase 1 study of Sarcoma and Soft Tissue Sarcoma, is active but no longer recruiting, sponsored by University of Iowa.
- ACTIVE NOT RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will enroll patients who have a diagnosis of locally advanced, unresectable or metastatic soft tissue or bone sarcoma (except gastrointestinal stromal tumors and Kaposi's sarcoma) from any site.
Conditions Studied
Interventions
- DRUG Ascorbate
Study Locations (1)
Iowa
- John - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2020-11-24 |
| Est. Completion | 2026-12-31 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04634227
The ClinicalTrials.gov registry entry for NCT04634227 describes a study currently listed as active not recruiting, categorized as Early Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 921-participant average among 122 other Sarcoma trials with a reported enrollment target (97% lower). The listed sponsor is University of Iowa, which has 228 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Sarcoma appearing as the primary indexed condition, and to 1 intervention - of which Ascorbate is the first listed.
NCT04634227 reports 1 study location spanning 1 distinct geographic area - top geographies include Iowa.
Frequently Asked Questions
What is clinical trial NCT04634227 about?
NCT04634227 is a clinical study titled "Gemcitabine Plus Ascorbate for Sarcoma in Adults (Pilot)". This study will enroll patients who have a diagnosis of locally advanced, unresectable or metastatic soft tissue or bone sarcoma (except gastrointestinal stromal tumors and Kaposi's sarcoma) from any site.
What is the current status of trial NCT04634227?
This trial is currently active not recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2020-11-24. Estimated completion is 2026-12-31.
What conditions does trial NCT04634227 study?
This clinical trial studies the following conditions: Sarcoma, Soft Tissue Sarcoma, Bone Sarcoma, Metastatic Bone Tumor, Unresectable Soft Tissue Sarcoma.
What interventions are being tested in trial NCT04634227?
The interventions under investigation include: Ascorbate (DRUG).
Who is sponsoring clinical trial NCT04634227?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04634227 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma
ACTIVE NOT RECRUITING · Early Phase 1
-
Irinotecan, Temozolomide and Bevacizumab in Combination With Existing High Dose Alkylator Based Chemotherapy for Treatment of Newly Diagnosed Patients With Desmoplastic Small Round Cell Tumor
ACTIVE NOT RECRUITING · Early Phase 1
-
68Ga-FAPi-46 PET/CT Scan in Imaging Patients With Sarcoma
ACTIVE NOT RECRUITING · Early Phase 1
-
WATCH (Wearable Artificial inTelligence for Cardiac Function and Health Monitoring)
RECRUITING · NA
-
LCI-SAR-BSTS-CTDNA-001: Circulating Tumor DNA Liquid Biopsy in Sarcoma Patients
RECRUITING
-
Palbociclib and Pembrolizumab in Sarcoma
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.